206 related articles for article (PubMed ID: 25670628)
1. miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.
Berg V; Rusch M; Vartak N; Jüngst C; Schauss A; Waldmann H; Hedberg C; Pallasch CP; Bastiaens PI; Hallek M; Wendtner CM; Frenzel LP
Blood; 2015 May; 125(19):2948-57. PubMed ID: 25670628
[TBL] [Abstract][Full Text] [Related]
2. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
3. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
4. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
6. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic protein depalmitoylation by acyl protein thioesterases.
Lin DT; Conibear E
Biochem Soc Trans; 2015 Apr; 43(2):193-8. PubMed ID: 25849916
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1.
Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia.
Groneberg C; Pickartz T; Binder A; Ringel F; Srock S; Sieber T; Schoeler D; Schriever F
Exp Hematol; 2003 Aug; 31(8):682-5. PubMed ID: 12901972
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
Kater AP; Dicker F; Mangiola M; Welsh K; Houghten R; Ostresh J; Nefzi A; Reed JC; Pinilla C; Kipps TJ
Blood; 2005 Sep; 106(5):1742-8. PubMed ID: 15914559
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
Sampalo A; Navas G; Medina F; Segundo C; Cámara C; Brieva JA
Blood; 2000 Nov; 96(9):3168-74. PubMed ID: 11049999
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
Blume CJ; Hotz-Wagenblatt A; Hüllein J; Sellner L; Jethwa A; Stolz T; Slabicki M; Lee K; Sharathchandra A; Benner A; Dietrich S; Oakes CC; Dreger P; te Raa D; Kater AP; Jauch A; Merkel O; Oren M; Hielscher T; Zenz T
Leukemia; 2015 Oct; 29(10):2015-23. PubMed ID: 25971364
[TBL] [Abstract][Full Text] [Related]
13. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
15. The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins.
Vartak N; Papke B; Grecco HE; Rossmannek L; Waldmann H; Hedberg C; Bastiaens PI
Biophys J; 2014 Jan; 106(1):93-105. PubMed ID: 24411241
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
17. Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2).
Milde S; Coleman MP
J Biol Chem; 2014 Nov; 289(47):32858-70. PubMed ID: 25271157
[TBL] [Abstract][Full Text] [Related]
18. Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals.
Speck SL; Wei X; Semenkovich CF
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1034-C1041. PubMed ID: 38344800
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterization and potential function of membrane Fas/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.
Kamihira S; Yamada Y; Hirakata Y; Tsuruda K; Sugahara K; Tomonaga M; Maeda T; Tsukasaki K; Atogami S; Kobayashi N
Br J Haematol; 1997 Dec; 99(4):858-65. PubMed ID: 9432034
[TBL] [Abstract][Full Text] [Related]
20. A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling.
Kathayat RS; Elvira PD; Dickinson BC
Nat Chem Biol; 2017 Feb; 13(2):150-152. PubMed ID: 27992880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]